Ajooni Biotech Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajooni Biotech's promoters have submitted their annual disclosure under SEBI regulation 31(4) confirming that neither they nor any persons acting in concert have created any encumbrance (pledge) on their shares during the financial year ending March 31, 2026. The disclosure covers promoter Jasjot Singh and promoter group members Parmjeet Kaur, Upneet Kaur, Ashmeet Kaur, and Ishneet Kaur. This is a standard regulatory filing required to be submitted yearly by companies where promoters hold substantial shares.
The confirmation that no shares are pledged is a positive signal for shareholders as it indicates promoters have not leveraged their holdings, reducing risk of forced selling. This filing does not indicate any change in ownership or stake.